scholarly journals International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

2019 ◽  
Vol 39 (1) ◽  
pp. 10-39 ◽  
Author(s):  
Brian T. Tsuji ◽  
Jason M. Pogue ◽  
Alexandre P. Zavascki ◽  
Mical Paul ◽  
George L. Daikos ◽  
...  
Keyword(s):  
Critical Care ◽  
Infectious Diseases ◽  
International Society ◽  
Clinical Pharmacy ◽  
European Society ◽  
Clinical Microbiology ◽  
Critical Care Medicine ◽  
Consensus Guidelines ◽  
International Consensus ◽  
International Consensus Guidelines

scholarly journals Review of the international consensus guidelines for the optimal use of the polymyxins

2019 ◽  
Vol 21 (4) ◽  
pp. 282-309 ◽  
Author(s):  
Ekaterina V. Eliseeva ◽  
Ilya Sulejmanovich Azyzov ◽  
N.A. Zubareva
Keyword(s):  
Infectious Diseases ◽  
Susceptibility Testing ◽  
Consensus Guidelines ◽  
International Consensus ◽  
Professional Societies ◽  
Optimal Dosing ◽  
Combined Use ◽  
Dosing Regimens ◽  
International Consensus Guidelines

Polymyxins are often the only agents that remain in vitro active against extensively resistant bacterial pathogens. However, the use of polymyxins is compromised by the number of unresolved issues, including the technical aspects of antimicrobial susceptibility testing, pharmacokinetic and pharmacodynamics parameters, optimal dosing regimens, and combined use with other antibiotics. All of the aspects of polymyxin use are discussed in detail in recently published «International consensus guidelines for the optimal use of the polymyxins», that was endorsed by the following professional societies: American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Antiinfective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).

scholarly journals Update on Changing Terminologies in Sepsis

2016 ◽  
Vol 36 (2) ◽  
pp. 178-183
Author(s):  
Ashish Kumar Simalti ◽  
Ranjit Ghuliani ◽  
Bindu T. Nair
Keyword(s):  
Septic Shock ◽  
Critical Care ◽  
Intensive Care ◽  
Intensive Care Medicine ◽  
European Society ◽  
Task Force ◽  
Critical Care Medicine ◽  
International Consensus ◽  
The Third ◽  
Sepsis And Septic Shock

Definitions of sepsis and septic shock were last revised in 2001. Since then there have been considerable advances in our understanding of pathophysiology, management, and epidemiology of sepsis, suggesting the need for reexamination. The European Society of Intensive Care Medicine and the Society of Critical Care Medicine convened a task force in January 2014 with objective to evaluate and, as needed, update definitions for sepsis and septic shock. Recommendations of this task force were published recently as “The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)”. The aim of this article is to generate awareness and discussion regarding this new important development.  

Sign in / Sign up

Export Citation Format

Share Document